Arrevus Alternatives & Competitors
12 companies similar to Arrevus — Conquering antibiotic resistance by targeting critical diseases with innovative...
Companies similar to Arrevus
Bugworks Research Inc.
Path breaking solutions to large unmet needs in Antimicrobial resistance (AMR) and immuno-...
Clarametyx Biosciences
Targeting biofilms to treat chronic respiratory disease
Phico Therapeutics Ltd.
Phico Therapeutics is a biotechnology company advancing the war on antibiotic resistance w...
Rival Readout
Competing with Arrevus? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
PolyPid Ltd.
Controlled, extended-release, local delivery of medication at effective release rates over...
ALSP, Inc.
Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative...
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Biohaven
A modern pharmaceutical company guided by science and inspired to change the lives of peop...
Sealife PHARMA® GMBH
Pioneering breakthroughs in marine biochemistry to combat drug-resistant infections and ad...
Allecra Therapeutics
Our Mission: Answering the call to action to fight antibiotic resistance
KBP Biosciences
At KBP we are consistently reminded that patient care is the end goal of what we do daily.
Adaptive Phage Therapeutics
To save lives or restore health as a leader in safe, rapidly deployable, cost-effective cu...
About Arrevus
Arrevus is a biotechnology and pharmaceutical startup, founded in 2015, with a mission to address antibiotic resistance in critical diseases. The company's focus lies in developing Designer Proline-rich Antimicrobial Peptide Chaperone Protein Inhibitors (DPCs) for diseases where antibiotic resistance has significant cl...
Antibiotic Resistance, DPCs, Drug Development, Clinical Implications, Bacterial Resistance, MRSA, Antimicrobial Peptides, Life-threatening Diseases, Patient Outcomes, Innovative Therapies, Pharmaceutical Research, Biomedical Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Arrevus: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Arrevus on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.